Presence of an Artificial Intelligence–powered Predictive Biomarker Is Associated with a Poor Response to Intravesical Bacillus Calmette-Guerin but Not to Intravesical Sequential Gemcitabine/Docetaxel in Patients with High-grade Non–muscle-invasive Bladder CancerVignesh T. Packiam, Patrick J. Hensley, Viswesh Krishna et al.|European Urology Oncology|2025Cited by 6
AN ARTIFICIAL INTELLIGENCE-POWERED MODEL TO PREDICT RESPONSE TO INTRAVESICAL BCG VERSUS GEMCITABINE-DOCETAXEL FOR HIGH-RISK NON-MUSCLE INVASIVE BLADDER CANCERVignesh T. Packiam, Michael J. O’Donnell, Ian M. McElree et al.|Urologic Oncology Seminars and Original Investigations|2025Cited by 0